Literature DB >> 10558884

Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule.

A Yachou1, R P Sékaly.   

Abstract

During HIV entry or resulting cell to cell fusion, the envelope glycoprotein gp120 binds first to the CD4 membrane distal domain and second to a chemokine receptor as coreceptor. Taking into consideration the relative length of these two molecules' extracellular parts, structural modulations of CD4 would be required to make the second interaction possible. In this work, we assessed the effect of gp120 binding on the conformation of CD4 expressed on cell surface. We demonstrated that following gp120 binding the avidity of some, but not all, monoclonal antibodies specific to epitopes, outside of the gp120-binding site, in D1, D3 and D4 domains of CD4 was decreased dramatically. This finding demonstrates that the gp120-CD4 interaction induces local and specific conformational changes of CD4 and constitutes functional evidence for hinge regions that could confer to this molecule the flexibility required for its various functions. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558884     DOI: 10.1006/bbrc.1999.1686

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

2.  Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.

Authors:  J Billington; T P Hickling; G H Munro; C Halai; R Chung; G G Dodson; R S Daniels
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

3.  Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

Authors:  Samuele E Burastero; Barbara Frigerio; Lucia Lopalco; Francesca Sironi; Daniela Breda; Renato Longhi; Gabriella Scarlatti; Silvana Canevari; Mariangela Figini; Paolo Lusso
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

4.  Probing the effect of force on HIV-1 receptor CD4.

Authors:  Raul Perez-Jimenez; Alvaro Alonso-Caballero; Ronen Berkovich; David Franco; Ming-Wei Chen; Patricia Richard; Carmen L Badilla; Julio M Fernandez
Journal:  ACS Nano       Date:  2014-10-14       Impact factor: 15.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.